Abstract 8-Hydroxyquinoline 1 reacts with ethyl chloroacetate in the presence of anhydrous K 2 CO 3 to produce ethyl (quinolin-8-yloxy)acetate 2. Treatment of 2 with hydrazine hydrate forms 2-(quinolin-8-yloxy)acetohydrazide 3, which on condensation with various aldehydes 4a-e gives
Introduction
The importance of the quinoline nucleus has been well demonstarted as illustrated by the large number of patents employing such species as chemotherapeutic agents. A number of biological activities have been associated with quinoline-containing compounds such as anti-inflammatory, antiallergic 1 , antimalarial 2 , antibacterial 3 , antiproliferative 4 , anticancer 5, 6 and antiparasitic 6 activities. Similarly, various thiazolidinones [7] [8] [9] have attracted considerable attention as they are also endowed with a wide range of pharmaceutical activities including CNS-depressant 10 , anaesthetic 11 , anticonvulsant 12 , antibacterial 13, 14 , antiviral 15 and antitumor 16 . Furthermore, drug research and development has led to the discovery of new pharmacologically active agents, including imidoxy 17, 18 compounds such as phthalimidoxy 19 and succinimidoxy 20 . Succinimidoxy
Results and Discussion
Ethyl (quinolin-8-yloxy)acetate 2 has been synthesized by condensation of 8-hydroxyquinoline 1 with ethyl chloroacetate in dry acetone for 18 h. In the IR spectrum of compound 2, bands in the range of 1747 cm -1 were obtained due to C=O stretching, as expected for the formation of 2. In the 1 H NMR spectrum, signals were found at δ 4.97 (singlet), 3.22 (quartet) and 2.28 (triplet), which showed the presence of a OCH 2 COOC 2 H 5 group. Compound 2, on treatment with hydrazine hydrate, yielded 2-(quinolin-8-yloxy)acetohydrazide 3. In the IR spectrum of 3, N-H stretching was observed at 3336-3257 cm -1 , which was absent in precursor 2. In the 1 H NMR spectrum, the characteristic proton of the CONH group was observed at δ 8.09 as a singlet. Compound 3, on reaction with various aldehydes 4a-e, gave N'-{[(1Z)-arylmethylene]-2-(quinolin-8-yloxy)}acetohydrazides 5a-e, which in turn afforded (2-aryl-4-oxo-3-{[quinolin-8-yloxy)acetyl]amino}1,3-thiazolidin-5-yl) acetic acids 6a-e on cyclization with mercaptosuccinic acid. The structures of the products were elucidated further on the basis of the C-S-C linkage in the five membered ring, which caused a weak but sharp absorption band at 760-710 cm -1 in all the compounds. A broad band in the range 3223-2891 cm -1 was obtained due to the OH stretching vibration and the C=O group was observed as a strong, sharp band at 1733-1674 cm -1 in all these compounds. The thiazolidinone CH was observed at δ 3.58-3.29 ppm as a triplet and the CH 2 protons at δ 3.27-3.04 ppm as a doublet, which indicated the formation of 6a-e. Compounds 6a-e were further converted into acid chloride derivatives 7a-e by reaction with SOCl 2 . Formation of the products was confirmed by disappearance of the IR band at 3223-2891 cm -1 due to the OH group and the appearance of a new band at 775-710 cm -1 due to the C-Cl bond. Subsequently, the chlorine atom in CH 2 CO-Cl was replaced by the succinimidoxy group to give the title compounds 8a-e. In the MS spectra of the latter, the molecular ion peak indicated the formation of compounds 8a-e. Attempts to use anhydrous K 2 CO 3 and Na 2 CO 3 in acetone to condense 7a-e with N-hydroxysuccinimide gave poor yields and the stronger base, NaH in THF, gave a sticky product that could not be crystallised. Better yields were obtained when TEA in DMF was used. Scheme I
Scheme 1
The synthesized compounds 8a-e were screened "in vitro" for antimicrobial activity. From the data presented in 
* Activity index = Inhibition area of the sample/inhibition area of the standard. C 1 = Amicacin; C 2 = Fluconazole. Diameter of disc is 5 mm
Antimicrobial screening
The disc-diffusion method 24 was used for the screening of anti-microbial activity. The antibacterial activity of the synthesized compounds 8a-e was tested against gram-positive bacteria i.e. Staphylococcus aureus, Staphylococcus albus, Streptococcus faecalis and gramnegative bacteria i.e., Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeuroginosa, Proteus mirabilis, Salmonella typhi using a nutrient agar medium. The antifungal activity of the compounds was screened against Candia albicans and Aspergillus fumigatus using Sabouraded dextrose agar medium. The sterilized medium (autoclaved at 121°C for 15 min.) was innoculated with the suspension of the micro-organisms and poured into a Petri dish to give a depth of 3-4 mm. The paper impregnated with the synthesized compounds 8a-e (300 µg/ml in DMF) was placed on the solidified medium. The plates were pre-incubated for 1 h at room temperature and incubated at 37° for 24 h and 48 h for antibacterial and antifungal activity, respectively. Amicacin (300 µg/ml) was used in anti-bacterial activity studies, whereas fluconazole (300 µg/ml) was used in antifungal activity studies, as reference compounds. After incubation, the relative susceptibility of the micro-organisms to the potential antimicrobial agent is demonstrated by a clear zone of growth inhibition around the disc. The inhibition zone caused by the various compounds on the micro-organisms was measured and the activity rated on the basis of the size of the inhibition zone. The observed zone of inhibition is presented in Table 1 .
Experimental Section
General Procedures. All melting points were determined in open capillary tubes and are uncorrected. The IR spectra were recorded on a Perkin-Elmer 1800 spectrophotometer. The 1 H NMR spectra were scanned on a DRX-300 MHz. Spectrometer (300 MHz) in CDCl 3 /DMSO d 6 using TMS as the internal standard and chemical shifts are expressed in δ ppm. The mass spectra were recorded on a Jeol SX-102 (FAB). m-Nitrobenzyl alcohol (NBA) was used as matrix. Purity of synthesized compounds was checked by TLC using silica gel-G. Spots were exposed in an iodine chamber. Other acid chlorides 7b-e were prepared in a similar manner and were characterized by their physical and analytical data. 
Ethyl (quinolin-8-yloxy)acetate (2).

